Atypical chemokine receptor 3 (ACKR3), a member of the G protein-coupled receptor (GPCR) superfamily, is widely expressed in a wide range of cancers, particularly in methotrexate-resistant prostate cancer tissue. This evidence concerns the gene ACKR3 and cancer.